Jonsson Comprehensive Cancer Center: Oligodendroglioma trials
The registry lists 10 Oligodendroglioma studies with Jonsson Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 6Phase 2 4No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT01635283Phase 2Results posted
- Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent GlioblastomaWithdrawnNCT03014804Phase 2
- Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaCompletedNCT00107185Phase 1
- Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedNCT00087061Phase 1/2
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00068510Phase 1
- Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsWithdrawnNCT00005083Phase 2
- Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaCompletedNCT00005082Not applicable